HJIM
RDY icon

Henry James International Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Henry James International Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-87,245
Closed -$1.28M – 114
2024
Q1 		$1.28M Sell
87,245
-1,735
-2% -$25.3K 0.39% 60
2023
Q4 		$1.24M Hold
88,980
– – 0.46% 55
2023
Q3 		$1.19M Buy
88,980
+13,355
+18% +$181K 0.52% 50
2023
Q2 		$955K Sell
75,625
-35
-0% -$409 0.41% 48
2023
Q1 		$861K Sell
75,660
-130
-0.2% -$1.4K 0.36% 52
2022
Q4 		$784K Buy
75,790
+1,665
+2% +$18K 0.38% 53
2022
Q3 		$776K Buy
74,125
+90
+0.1% +$959 0.43% 49
2022
Q2 		$820K Buy
74,035
+50
+0.1% +$544 0.41% 50
2022
Q1 		$825K Sell
73,985
-555
-0.7% -$6.29K 0.33% 63
2021
Q4 		$975K Buy
74,540
+140
+0.2% +$1.76K 0.3% 78
2021
Q3 		$969K Sell
74,400
-47,615
-39% -$634K 0.31% 79
2021
Q2 		$1.79M Buy
122,015
+1,025
+0.8% +$14.3K 0.51% 54
2021
Q1 		$1.49M Buy
120,990
+155
+0.1% +$1.99K 0.45% 57
2020
Q4 		$1.72M Sell
120,835
-100
-0.1% -$1.35K 0.6% 51
2020
Q3 		$1.68M Sell
120,935
-1,145
-0.9% -$13.6K 0.69% 46
2020
Q2 		$1.29M Sell
122,080
-2,825
-2% -$28.7K 0.54% 48
2020
Q1 		$1.01M Sell
124,905
-565
-0.5% -$4.71K 0.52% 46
2019
Q4 		$1.02M Hold
125,470
– – 0.4% 71
2019
Q3 		$951K Buy
125,470
+150
+0.1% +$1.12K 0.41% 64
2019
Q2 		$939K Sell
125,320
-4,270
-3% -$33.6K 0.4% 63
2019
Q1 		$1.05M Buy
129,590
+875
+0.7% +$6.65K 0.48% 56
2018
Q4 		$971K Buy
+128,715
New +$905K 0.63% 49

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Henry James International Management's RDY Position: Q2 2024 in Review

Henry James International Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 87,245 shares — an estimated $1.28M sold.

Henry James International Management first reported a position in RDY in Q4 2018 and held it in 22 quarters. The position peaked at $1.79M in Q2 2021. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Henry James International Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • Henry James International Management sold 87,245 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $1.28M.
  • Henry James International Management first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 22 quarters.
  • Henry James International Management's Dr. Reddy's Laboratories position peaked at $1.79M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Henry James International Management's 13F filing for Q2 2024, filed 12 Jul 2024.